KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) issued its quarterly earnings results on Thursday. The specialty pharmaceutical company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.76) by ($0.04), MarketWatch Earnings reports. KalVista Pharmaceuticals Stock Performance Shares of NASDAQ KALV opened at $8.16 on Friday. The company has a 50 […]
KalVista Pharmaceuticals (NASDAQ:KALV) Releases Earnings Results, Misses Expectations By $0 04 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
In this article, we will take a look at the 16 most undervalued small-cap stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds. Despite strong signs that the central bank would be ready to hit brakes on its […]
In this piece, we will take a look at billionaire Marc Lasry’s top ten stock picks. If you want to skip our introduction to the billionaire hedge fund boss and the general investing climate, then take a look at Billionaire Marc Lasry’s Top 5 Stock Picks. Marc Lasry is a hedge fund billionaire who started […]